DJIA 16,921.17 9.06 0.05%
NASDAQ 4,467.43 24.73 0.56%
S&P 500 1,973.70 3.75 0.19%
market minute promo

320.92 16.41 (5.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $321.23 5.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $328.55
Previous Close $304.51
Daily Range $315.00 - $336.94
52-Week Range $227.64 - $352.49
Market Cap $32.4B
P/E Ratio 87.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,979,616
Average Daily Volume 968,800
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

S&P 500 Movers: GNW, EW

Nasdaq 100 Movers: GRMN, REGN

Jim Cramer's Mad Dash: Good News for Regeneron

Trade-Ideas: Regeneron Pharmaceuticals (REGN) Is Today's Pre-Market Leader Stock

Sanofi And Regeneron Report Positive Top-Line Results From Nine Phase 3 Trials Of Alirocumab In Peop

Sanofi And Regeneron Report Positive Top-Line Results From Nine Phase 3 Trials Of Alirocumab In People With Hypercholesterolemia

3 Stocks Reiterated As A Buy: GM, DD, REGN

Regeneron Pharmaceuticals Inc Stock Upgraded (REGN)

REGN, ILMN And CELG, Pushing Health Care Sector Downward

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog

3 Stocks Reiterated As A Hold: NTAP, FSLR, REGN

See More REGN News...

REGN's Top Competitors

REGN $320.92 (5.39%)
Current stock: REGN
AMGN $130.40 (5.75%)
Current stock: AMGN
GILD $94.00 (1.09%)
Current stock: GILD
BIIB $347.94 (1.82%)
Current stock: BIIB